DPP4 and infection: Meta-analyses illustrate that DPP4 inhibitors do not raise the risk of acquiring infections (29–31), a feature that is also confirmed by Yang et al. (32), who did not report a high risk of infections due to pathogens with DPP4 inhibitors.